Clinical diagnosis of cerebral amyloid angiopathy: Validation of the Boston Criteria
Tóm tắt
Từ khóa
Tài liệu tham khảo
Vinters HV, Gilbert JJ: Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke 1983, 14:924–928.
Rosand J, Hylek EM, O’Donnell HC, Greenberg SM: Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study. Neurology 2000, 55:947–951.
Greenberg SM, Rebeck GW, Vonsattel JP, et al.: Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol 1995, 38:254–259.
Greenberg SM, Briggs ME, Hyman BT, et al.: Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke 1996, 27:1333–1337.
Gilbert JJ, Vinters HV: Cerebral amyloid angiopathy: incidence and complications in the aging brain. I. Cerebral hemorrhage. Stroke 1983, 14:915–923.
Ellis RJ, Olichney JM, Thal LJ, et al.: Cerebral amyloid angiopathy in the brains of patients with Alzheimer’s disease: the CERAD experience, Part XV. Neurology 1996, 46:1592–1596.
Levy E, Carman MD, Fernandez-Madrid IJ, et al.: Mutation of the Alzheimer’s disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 1990, 248:1124–1126.
Grabowski TJ, Cho HS, Vonsattel JP, et al.: Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol 2001, 49:697–705.
Greenberg SM, Vonsattel JP: Diagnosis of cerebral amyloid angiopathy. Sensitivity and specificity of cortical biopsy. Stroke 1997, 28:1418–1422.
Masuda J, Tanaka K, Ueda K, Omae T: Autopsy study of incidence and distribution of cerebral amyloid angiopathy in Hisayama, Japan. Stroke 1988, 19:205–210.
Greenberg SM, Vonsattel JP, Segal AZ, et al.: Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy. Neurology 1998, 50:961–965.
McCarron MO, Nicoll JA: High frequency of apolipoprotein E epsilon 2 allele is specific for patients with cerebral amyloid angiopathy-related haemorrhage. Neurosci Lett 1998, 247:45–48.
Nicoll JA, Burnett C, Love S, et al.: High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol 1997, 41:716–721.
McCarron MO, Nicoll JA, Stewart J, et al.: The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol 1999, 58:711–718.
Premkumar DR, Cohen DL, Hedera P, et al.: Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer’s disease. Am J Pathol 1996, 148:2083–2095.
Alonzo NC, Hyman BT, Rebeck GW, Greenberg SM: Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels. J Neuropathol Exp Neurol 1998, 57:353–359.
O’Donnell HC, Rosand J, Knudsen KA, et al.: Apolipoprotein E genotype and the risk of recurrent lobar intracerebral hemorrhage. N Engl J Med 2000, 342:240–245.
Kase CS: Lobar hemorrhage. In Intracerebral Hemorrhage. Edited by Kase CS, Caplan LR. Boston: Butterworth-Heinemann; 1994:363–382.
Itoh Y, Yamada M, Hayakawa M, et al.: Cerebral amyloid angiopathy: a significant cause of cerebellar as well as lobar cerebral hemorrhage in the elderly. J Neurol Sci 1993, 116:135–141.
Cuny E, Loiseau H, Rivel J, et al.: Amyloid angiopathy-related cerebellar hemorrhage. Surg Neurol 1996, 46:235–239.
Yamada M, Itoh Y, Otomo E, et al.: Subarachnoid haemorrhage in the elderly: a necropsy study of the association with cerebral amyloid angiopathy. J Neurol Neurosurg Psychiatry 1993, 56:543–547.
Ropper AH, Davis KR: Lobar cerebral hemorrhages: acute clinical syndromes in 26 cases. Ann Neurol 1980, 8:141–147.
Schutz H, Bodeker RH, Damian M, et al.: Age-related spontaneous intracerebral hematoma in a German community. Stroke 1990, 21:1412–1418.
Helweg-Larsen S, Sommer W, Strange P, et al.: Prognosis for patients treated conservatively for spontaneous intracerebral hematomas. Stroke 1984, 15:1045–1048.
Broderick JP, Brott TG, Duldner JE, et al.: Volume of intracerebral hemorrhage. A powerful and easy-to-use predictor of 30-day mortality [comment]. Stroke 1993, 24:987–993.
Kase CS, Williams JP, Wyatt DA, Mohr JP: Lobar intracerebral hematomas: clinical and CT analysis of 22 cases. Neurology 1982, 32:1146–1150.
Massaro AR, Sacco RL, Mohr JP, et al.: Clinical discriminators of lobar and deep hemorrhages: the Stroke Data Bank [comment]. Neurology 1991, 41:1881–1885.
Juvela S: Risk factors for impaired outcome after spontaneous intracerebral hemorrhage [comment]. Arch Neurol 1995, 52:1193–1200.
Bailey RD, Hart RG, Benavente O, Pearce LA: Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage. Neurology 2001, 56:773–777.
Greenberg SM, Vonsattel JP, Stakes JW, et al.: The clinical spectrum of cerebral amyloid angiopathy: presentations without lobar hemorrhage. Neurology 1993, 43:2073–2079.
Olichney JM, Hansen LA, Hofstetter CR, et al.: Cerebral infarction in Alzheimer’s disease is associated with severe amyloid angiopathy and hypertension. Arch Neurol 1995, 52:702–708.
Cadavid D, Mena H, Koeller K, Frommelt RA: Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. J Neuropathol Exp Neurol 2000, 59:768–773.
Okazaki H, Reagan TJ, Campbell RJ: Clinicopathologic studies of primary cerebral amyloid angiopathy. Mayo Clin Proc 1979, 54:22–31.
Imaoka K, Kobayashi S, Fujihara S, et al.: Leukoencephalopathy with cerebral amyloid angiopathy: a semiquantitative and morphometric study. J Neurol 1999, 246:661–666.
Gray F, Dubas F, Roullet E, Escourolle R: Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy. Ann Neurol 1985, 18:54–59.
Fountain NB, Eberhard DA: Primary angiitis of the central nervous system associated with cerebral amyloid angiopathy: report of two cases and review of the literature [comment]. Neurology 1996, 46:190–197.
Osumi AK, Tien RD, Felsberg GJ, Rosenbloom M: Cerebral amyloid angiopathy presenting as a brain mass. Am J Neuroradiol 1995, 16:911–915.
Spaar FW, Goebel HH, Volles E, Wickboldt J: Tumor-like amyloid formation (amyloidoma) in the brain. J Neurol 1981, 224:171–182.
Vonsattel JP, Myers RH, Hedley-Whyte ET, et al.: Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study. Ann Neurol 1991, 30:637–649.
Greenberg SM, Finklestein SP, Schaefer PW: Petechial hemorrhages accompanying lobar hemorrhage: detection by gradient-echo MRI. Neurology 1996, 46:1751–1754.
Greenberg SM, O’Donnell HC, Schaefer PW, Kraft E: MRI detection of new hemorrhages: potential marker of progression in cerebral amyloid angiopathy. Neurology 1999, 53:1135–1138.
Greenberg SM, Rosand J: Outcome markers for clinical trials in cerebral amyloid angiopathy. Amyloid 2001, 8:56–60.
McCarron MO, Nicoll JA: APOE genotype in relation to sporadic and Alzheimer-related CAA. In Cerebrovascular Amyloidosis in Alzheimer’s Disease and Related Disorders. Edited by Verbeek MN, Vinters HV, de Waal RMV. Dordrecht, Netherlands: Wolters Kluwer; 2000.
Greenberg SM: Cerebral amyloid angiopathy: prospects for clinical diagnosis and treatment. Neurology 1998, 51:690–694.